Bonine
Product Images NDC 63736-044

2 FDA label images from Insight Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bonine (NDC 63736-044). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Insight Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (Box of 8 Tablets)

Principal Display Panel (Box of 8 Tablets)
Bonine Kids chewable travel tablet packaging label for motion sickness prevention and treatment with cyclizine hydrochloride as the active ingredient. The label indicates an 8-count package in berry blast flavor. Manufactured by Insight Pharmaceuticals, the packaging highlights reduced drowsiness compared to original Dramamine and includes directions, warnings, and drug facts panels.*
FDA Label Image

Principal Display Panel (Box of 12 Tablets)

Principal Display Panel (Box of 12 Tablets)
Packaging label for Bonine Kids chewable travel tablets, berry blast flavor by Insight Pharmaceuticals. The label promotes 12 chewable tablets, bonus 50% more for the price of 8 tablets. It is especially formulated for children to prevent and treat motion sickness and contains cyclizine hydrochloride as the active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.